- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 417/14 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group containing three or more hetero rings
Patent holdings for IPC class C07D 417/14
Total number of patents in this class: 10108
10-year publication summary
|
601
|
553
|
627
|
598
|
614
|
568
|
596
|
760
|
695
|
595
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4824 |
292 |
| Merck Sharp & Dohme LLC | 3732 |
207 |
| Novartis AG | 10626 |
162 |
| Takeda Pharmaceutical Company Limited | 2716 |
151 |
| Janssen Pharmaceutica N.V. | 3350 |
150 |
| Boehringer Ingelheim International GmbH | 4637 |
142 |
| F. Hoffmann-La Roche AG | 7934 |
140 |
| Gilead Sciences, Inc. | 2085 |
136 |
| Amgen Inc. | 4163 |
121 |
| Hoffmann-La Roche Inc. | 3534 |
98 |
| Merck Patent GmbH | 5755 |
93 |
| Dana-Farber Cancer Institute, Inc. | 2621 |
92 |
| Abbvie Inc. | 1814 |
75 |
| LG Chem, Ltd. | 17682 |
73 |
| Cancer Research Technology Limited | 524 |
71 |
| Genentech, Inc. | 4008 |
70 |
| AstraZeneca AB | 2851 |
68 |
| Syngenta Crop Protection AG | 6236 |
68 |
| Rigel Pharmaceuticals, Inc. | 532 |
65 |
| Syngenta Participations AG | 1742 |
63 |
| Other owners | 7771 |